Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (11) , 2416-2421
- https://doi.org/10.1161/01.atv.0000184760.95957.d6
Abstract
Objective— This study investigates effects of short-term administration of high-density lipoproteins (HDL) and a statin on atherosclerosis in cholesterol-fed rabbits. Effects of HDL apolipoprotein and phospholipid composition have also been investigated. Methods and Results— Aortic atherosclerosis was established over 17 weeks in 46 rabbits by balloon denudation and cholesterol feeding. During the past 5 days of the cholesterol-feeding period, animals received: (1) no treatment; (2) oral atorvastatin 5 mg/kg on each of the 5 days; or (3) infusions of HDL (8 mg/kg apolipoprotein A-I) on days 1 and 3 of the treatment phase. After euthanization, lesion size and composition were assessed by histological and immunohistochemical analysis. HDL (but not atorvastatin) reduced lesion size by 36% (PPPPPPConclusion— Infusing small amounts of HDL rapidly reduces lesion size and is comparable to atorvastatin in promoting a stable plaque phenotype. Atherosclerosis was established in rabbit aortas by balloon denudation and 17 weeks of cholesterol feeding. Infusing HDL during the last 5 days reduced lesion size, increased the ratio of smooth muscle cells to macrophages, and reduced metalloproteinase while increasing thrombomodulin expression in the lesions, consistent with stabilization of plaques by HDL.Keywords
This publication has 31 references indexed in Scilit:
- Antiinflammatory Properties of HDLCirculation Research, 2004
- Metabolism of ApoA-I as Lipid-Free Protein or as Component of Discoidal and Spherical Reconstituted HDLsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free CholesterolJournal of Biological Chemistry, 1995
- Atherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-IIScience, 1993
- Evidence in vitro that hepatic lipase reduces the concentration of apolipoprotein A-I in rabbit high-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.Journal of Clinical Investigation, 1990
- Effects of dietary fats on the fluidity of human high-density lipoprotein: Influence of the overall composition and phospholipid fatty acidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Effect of saturated and unsaturated fat diets on molecular species of phosphatidylcholine and sphingomyelin of human plasma lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981